Acknowledgements Dept of Chemical Engineering, Monash Materials and Methods The core nanoparticles will be composed of mesoporous silica with the target.

Slides:



Advertisements
Similar presentations
“Innovation to Legacy Manufacturing”
Advertisements

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Potential prophylactic BCG Prime-booster Gaëlle Noël Kidist Bobosha Subgroup A2 March 16 th, 2011.
Applications of Nanoparticles for Delivery of Therapeutic Agents Frank Jeyson Hernández Topics of Nanobiotechnology 30 June, 2004.
Affinity Ligands for Plasmid DNA Purification YING HAN, GARETH M. FORDE Chemical Engineering Department, Monash University, Vic 3800, Australia Materials.
Plasmid DNA production – A scaleable, whole-system approach to fermentation and downstream purification Michael Danquah 1, Jamil Chowdhury 2, Gareth M.
Industrially Scaleable Process for the Purification and Refolding of Inclusion Body Recombinant Protein BELINDA C. CLARKE 1, GARETH M. FORDE 1, CHARLES.
CHAPTER 31 Genetic Engineering and Biotechnology.
Small Intestine pH mg/ml tripsin Alia M. Al-Lawati 1, Rajprathab Gopiraj 1, Elena Virtue 2, Diane E. Webster 2 and Gareth M. Forde 1. Process.
Cancer Gene Therapy …Using Tumor Suppressor Genes.
Sterile & Parenteral Preparations
General Microbiology (Micr300) Lecture 11 Biotechnology (Text Chapters: ; )
Nanotechnology in Drug Delivery for Cancer Current Technologies
Construction of an expression system for HBV pseudo-viral particles Candidate No: Candidate No:
Sol-Millennium MVP Injection Solution Contributor to Safety Injection In Immunization Service.
Nanoparticles and their medical applications
About Microbionical About Founded Business idea: Commercialize Seek & Heal™ technology. ACO Läkemedel, Stockholm – pharmaceutical development.
Nanotechnology and its Application in Medicine
WHO Health Care Waste Management Waste Minimization Role of Manufacturers of Injection Equipment Protection of the Human Environment (PHE) Richard M. Carr.
By Aizaz Khan. Maurice Hilleman discover measle vaccine. Maurice Hilleman Maurice Hilleman's measles vaccine is estimated to prevent 1 million deaths.
Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.
Edible Vaccines: eating our way to the eradication of disease.
L OUISIANA T ECH U NIVERSITY College of Engineering and Science Encapsulated silica colloidal particles using layer by-layer electrostatic self-assembly.
.  Based on particle size and surface charge characterization studies, both nanoparticles have successfully been synthesized.  Successful conjugation.
Edible Vaccines. HOW IS IT DONE Approach 1 DNA sequences encoding antibodies (molecule which is able to recognise a disease-causing agent) are inserted.
4 Molecular biology in medicine Figure 4.1 The influenza virus has two surface proteins: neuraminidase and haemagglutinin. These proteins change continually,
Pharmacy Equipment. activated charcoal A form of carbon used to treat certain poisonings and intestinal bloat and gas.
Gene Therapy (III) “Non-Viral Gene Transfer Methods” Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
NANOTECHNOLOGIES: THE NEW GENERATION OF MEDICINE Dr Mariano Licciardi.
Unit 3: Interphase Nucleus. Interphase Nucleus Heterochromatin Heterochromatin: dark, condensed DNA that is transcriptionally inactive during interphase.
Transfection.
Ensuring the safety of patients and healthcare workers Grete Christensen, President European Federation of Nurses Association EFN.
Title: Anisotropic Colloidal Magnetic Nanostructures NSF Award Numbers: # Recent years have witnessed a remarkable convergence of physical sciences,
Chapter 12 Immunity and Body Defenses
1.  Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Most common.
Method of Administering Medication Kevin Murphy. Administration Methods One way to administer a drug is to taking it orally either by pills, capsules,
An Innovative Platform for Rapid and Multiplexed Cancer Biomarker Detection with Surface-enhanced Raman Scattering Nanotags Dr. Yuling Wang (ARC DECRA.
DELIVERY OF PROTEINS USING BIODEGRADABLE POLYMERS Mahesh V. Chaubal Guilford Pharmaceuticals Inc. Baltimore, MD 21224
1 Carbon Nanotube In Biology Lawanya Raj Ojha Graduate Student Department of Chemistry, OSU, Stillwater.
Nanoparticle is a general term covering any structure built on a nanometer scale. In medical science, nanoparticles are structures on a nm scale,
Modular Nanodevices for Creation of Smart Adaptable Vaccine Delivery Vehicles Tarek M. Fahmy Dept. of Biomedical Engineering, Yale University Several key.
Drug Encapsulation Using Supercritical CO₂ By: Maggie L. Plante │ UNH Manchester │ Abstract Supercritical CO₂ can help green the.
Viruses Mader-Chapter 21.
Gene therapy and Viral Vectors Lecture 6. Contents Introduction to gene therapy Delivery of Therapeutic Genes Gene Therapy Targets Delivery Modes Steps.
AUSTRALIAN SCIENTISTS Natalie Sarkez Year 12 Biology.
Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.
Gene Therapy (I) “Introduction to Gene Therapy”
Gene Therapy. What is Gene Therapy? Gene Therapy is the insertion of genes into an individual’s cells and tissues to treat a disease. Gene Therapy is.
Porous-Wall Hollow Glass Microsphere as novel potential nanocarriers for biomedical applications Shuyi Li, M.D., Ph.D. NIH Nanomedicine Center for Nucleoprotein.
Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit.
Transfection can be accomplished through the use of cationic polymers such as DEAE-dextran or polyethylenimine. The negatively charged DNA binds to the.
Viral vaccines  .
Purified proteins Recombinant proteins Whole inactivated or attenuated organisms DNA encoded antigens Bacterial products Toxins Cytokines, peptides Oil.
Recombinant Hormones and Drugs.  Many human disorders traced to absence or malfunction of a protein normally synthesized in the body  eg. Sickle cell.
Vaccine; To be effective  Must stimulate as many of the body's defence mechanisms as possible.  It is not necessary to get 100% uptake of vaccine in.
Moral Monday BW Should patients be given refunds when a vaccine doesn’t work?
Edible Vaccines.
Xiaopeng Min, Li Wang, Yin Wang (Advisor)
Drug Encapsulation Using Supercritical CO₂
Novel Drug Delivery System
A typical enveloped virus
{ INTRODUCTION APPROACH
Edible Vaccines: eating our way to the eradication of disease
Chapter 13: Medical Applications of Nanoscience
Nanotechnology تقانة الصغائر.
Drug Delivery Systems Pharmaceutical technology Petra University.
Immunologic Basis of Vaccine Vectors
US Army Medical Research and Materiel Command
Presentation transcript:

Acknowledgements Dept of Chemical Engineering, Monash Materials and Methods The core nanoparticles will be composed of mesoporous silica with the target size of around nm by modification of commercially available colloidal silica with electrolyte. This synthesis process can be categorized as assembly of colloidal silica. The core nanoparticles and pDNA will be dispersed throughout a poly ‑ ε ‑ caprolactone (biodegradable polymer) matrix. Protein will be immobilized in core nanoparticles which are encapsulated by a biodegradable polymer where the pDNA vaccine prime is also encapsulated. Nanoparticle–Biodegradable Polymer Particles for Staged Delivery of a Prime–Boost Vaccination JENNY HO, Dr. GARETH M. FORDE, Dr. HUANTING WANG Department of Chemical Engineering, Melbourne, Victoria, 3800, Australia. Nanoparticle–Biodegradable Polymer Particles for Staged Delivery of a Prime–Boost Vaccination JENNY HO, Dr. GARETH M. FORDE, Dr. HUANTING WANG Department of Chemical Engineering, Melbourne, Victoria, 3800, Australia. The Problem Over 36 million children born every year do not have access to vaccines that are routinely given to children in the industrialized world as the lack of medical training and financial resources continues to impede the introduction of new vaccines to low-income countries. Additionally, the reuse of syringes and needles in the absence of sterilization exposes millions of people to infection. In some countries the proportion of injections given with syringes or needles reused without sterilization is as high as 70%. As a result, an inhalable particle capable of providing the staged delivery of a vaccine prime/boost would represent a major breakthrough in vaccine delivery technology. The use of plasmid DNA (pDNA) as an initial vaccine prime is gaining interest as it is non-infectious, encodes only the antigen of interest and does not contain heterologous protein components which the host may respond to. However, naked pDNA is not particularly suitable for direct injection as it is hindered by its instability in biological fluid and is degraded by serum nucleases. Thus, it is necessary to develop an efficient delivery system that can transfer pDNA into cells. The central challenge is to develop a cheap, simple delivery mechanism that can deliver pDNA safely to a patient while simultaneously obtaining high cell transfection efficiencies. The Objective The aim of this research is to produce a smart, multifunctional nanoparticle-biodegradable polymer particle for the staged delivery of a vaccine prime/booster after a single administration. The particle will have the potential to be administered orally or nasally. Plasmid DNA will be protected from degradation which will lead to increased transfection efficiencies and a subsequent reduction in the amount of pDNA required. The smart particles will be designed to deliver pDNA and proteins at discreet time intervals in order to achieve a pDNA- prime / protein-boost vaccination. Plasmid DNA Prime Biodegradable Polymer Matrix Colloidal Silica Mesoporous Silica Spectrum data for calcinated sample shown that the mesoporous silica contain mostly silica, sodium and chloride. Protein Boost Spectrum data for a calcinated sample shows that mesoporous silica consists mostly of silica, sodium and chloride